Cite
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.
MLA
Mostafa, Ahmed, et al. “FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.” Pharmaceuticals (14248247), vol. 13, no. 12, Dec. 2020, p. 443. EBSCOhost, https://doi.org/10.3390/ph13120443.
APA
Mostafa, A., Kandeil, A., A. M. M. Elshaier, Y., Kutkat, O., Moatasim, Y., Rashad, A. A., Shehata, M., Gomaa, M. R., Mahrous, N., Mahmoud, S. H., GabAllah, M., Abbas, H., Taweel, A. E., Kayed, A. E., Kamel, M. N., Sayes, M. E., Mahmoud, D. B., El-Shesheny, R., Kayali, G., & Ali, M. A. (2020). FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (14248247), 13(12), 443. https://doi.org/10.3390/ph13120443
Chicago
Mostafa, Ahmed, Ahmed Kandeil, Yaseen A. M. M. Elshaier, Omnia Kutkat, Yassmin Moatasim, Adel A. Rashad, Mahmoud Shehata, et al. 2020. “FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.” Pharmaceuticals (14248247) 13 (12): 443. doi:10.3390/ph13120443.